Article information
Full text is only aviable in PDF
Bibliografía
[1.]
T.N. Finley, E.W. Swenson, W.S. Curran, G.L. Hurber, A.J. Landman.
Bronchopulmonary lavage in normal subjects and patients with obstructive lung disease.
Ann Intern Med, 66 (1967), pp. 651-658
[2.]
H.Y. Reynolds, H.H. Newball.
Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.
J Lab Clin Med, 84 (1974), pp. 559-573
[3.]
Castella Riera J, Ancochea Bermúdez J, Llorente Fernández JL, Puzo Ardanuy C, Sanchís Aldás J, Sueiro Bendito A, et al. Lavado broncoalveolar. Disponible en: http://www.separ.es/servicios/publicaciones/recomen/rec05.pdf
[4.]
J.L. Pérez-Arellano, J. Ancochea.
El lavado broncoalveolar en la enfermedad alveolointersticial no infecciosa.
Actualizaciones Separ (vol. 1), pp. 187-236
[5.]
A.T. Hill, E.J. Campbell, S.L. Hill, D.L. Bayley, R.A. Stockley.
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.
Am J Med, 109 (2000), pp. 288-295
[6.]
S. Sethi.
Infectious etiology of acute exacerbations of chronic bronchitis.
Chest, 117 (2000), pp. 380-385
[7.]
N.F. Voelkel, R. Tuder.
COPD: exacerbation.
Chest, 117 (2000), pp. 376-379
[8.]
A. Torres, M. El-Ebiary.
Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia.
Chest, 117 (2000), pp. 198-202
[9.]
S. Ewig, N. Soler, J. Gonzalez, R. Celis, M. El-Ebiary, A. Torres.
Evaluation of antimicrobial treatment in mechanically ventilated patients with severe chronic obstructive pulmonary disease exacerbations.
Crit Care Med, 28 (2000), pp. 692-697
[10.]
B. Allegranzi, A. Cazzadori, G. Di Perri, S. Bonora, M. Berti, L. Franchino, et al.
Concentrations of single-dose meropenem (1 g i.v.) in bronchoalveolar lavage and epithelial lining fluid.
J Antimicrob Chemother, 46 (2000), pp. 319-322
[11.]
J.E. Conte, J.A. Golden, M. McQuitty, J. Kipps, E.T. Lin, E. Zurlinden.
Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.
Antimicrob Agents Chemother, 44 (2000), pp. 985-990
[12.]
A. Sign, K. Trebesius, A. Roggenkamp, H. Russmann, K. Tybus, F. Pfaff, et al.
Evaluation of diagnositic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups.
J Clin Microbiol, 38 (2000), pp. 1461-1467
[13.]
H.S. Oz, W.T. Hughes.
Search for Pneumocystis carinii DNA in upper and lower respiratory tract of humans.
Diagn Microbiol Infect Dis, 37 (2000), pp. 161-164
[14.]
A.J. Huaringa, F.J. Leyva, J. Signes-Costa, R.C. Morice, I. Raad, A.A. Darwish, et al.
Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients.
Bone Marrow Transplant, 25 (2000), pp. 975-979
[15.]
E.I. De Brauwer, J.A. Jacobs, F. Nieman, C.A. Bruggeman, S.S. Wagenaar, M. Drent.
Cytocentrifugation conditions affecting the differential cell count in bronchoalveolar lavage fluid.
Anal Quant Cytol Histol, 232 (2000), pp. 416-422
[16.]
E.I. De Brauwer, M. Drent, P.G. Mulder, C.A. Bruggeman, S.S. Wagenaar, J.A. Jacobs.
Differential cells analysis of cytocentrifuged bronchoalveolar fluid samples affected by the area cointed.
Anal Quant Cytol Histol, 22 (2000), pp. 143-149
[17.]
D. Petkova, A. Xaubet, C. Picado, X. Filella, C. Agusti, P. Luburich, et al.
Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
Respir Med, 94 (2000), pp. 345-349
[18.]
F.L. De Pater-Huijsen, C.M. Van der Loos, M.J. De Riemer, J.S. Van der Zee, H.M. Jansen, T.A. Out.
Double staining of intracellular cytokine proteins and T-lymphocyte subsets. Evaluation of the method in blood and bronchoalveolar lavage fluid.
Histochem J, 32 (2000), pp. 3-11
[19.]
A. Angel-Moreno Maroto, J. Rodriguez Ramirez, J.L. Perez Arellano.
Sarcoidosis ¿enfermedad o sindrome?.
Piel, 13 (1998), pp. 227-241
[20.]
K. Tani, F. Ogushi, L. Huang, T. Kawuano, H. Tada, N. Hariguchi, et al.
CD13/aminopeptidase N. a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis.
Am J Respir Crit Care Med, 161 (2000), pp. 1636-1642
[21.]
A. Prasse, C.G. Georges, H. Biller, H. Hamm, H. Matthys, W. Luttmann, et al.
Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.
Clin Exp Immunol, 122 (2000), pp. 241-248
[22.]
K. Shigehara, N. Shijubo, M. Ohmichi, R. Takahashi, S. Kon, H. Okamura, et al.
Increased levels of interleukin-18 in patients with pulmonary sarcoidosis.
Am J Respir Crit Care Med, 162 (2000), pp. 1979-1982
[23.]
C.M. Greene, G. Meachery, C.C. Taggart, C.P. Rooney, R. Coakley, S.J. O'Neill, et al.
Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis.
J Immunol, 165 (2000), pp. 4718-4724
[24.]
D.S. Kim, Y.G. Jeon, T.S. Shim, C.M. Lim, S.D. Lee, Y. Koh, et al.
The value of interleukin-12 as an activity marker of pulmonary sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis, 17 (2000), pp. 271-276
[25.]
k. Shigehara, N. Shijubo, M. Ohmichi, G. Yamada, R. Takahashi, H. Okamura, et al.
IL-12 and IL-18 are increased and stimulate IFNgamma production in sarcoid lungs.
J Immunol, 166 (2001), pp. 642-649
[26.]
Y.P. Moodley, T. Dorasamy, S. Venketasamy, V. Naicker, U.G. Lalloo.
Correlation of CD4:cD8 ratio and tumour necrosis factor TNF-α levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis.
Thorax, 55 (2000), pp. 696-699
[27.]
M.N. Kolopp-Sarda, C. Kohler, A.K. De March, M.C. Bene, G. Faure.
Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis.
Lab Invest, 80 (2000), pp. 1065-1069
[28.]
J.L. Perez Arellano, R. Sanchez, I. Pastor, J.E. Losa, M.J. Garcia, L. Gonzalez Villaron.
Pathogenesis of hypersensitivity pneumonitis.
Allergol Immunopathol, 17 (1989), pp. 225-232
[29.]
A. Pardo, R. Barrios, M. Gaxiola, L. Segura-Valdez, G. Carrillo, A. Estrada, et al.
Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis.
Am J Respir Crit Care Med, 161 (2000), pp. 1698-1704
[30.]
G.M. Tremblay, A.M. Wolbink, Y. Cormier, C.E. Hack.
Granzyme activity in the inflamed lung is not controlled by endogenous serine proteinase inhibitors.
J Immunol, 165 (2000), pp. 3966-3969
[31.]
A.L. Katzenstein, J.L. Myers.
Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.
Am J Respir Crit Care Med, 157 (1998), pp. 1301-1315
[32.]
J.A. Bjoraker, J.H. Ryu, M.K. Edwin, J.L. Myers, H.D. Tazelaar, D.R. Schroeder, et al.
Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 157 (1998), pp. 199-203
[33.]
V. Cottin, A.V. Donsbeck, D. Revel, R. Loire, J.F. Cordier.
Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients.
Am J Respir Crit Care Med, 158 (1998), pp. 1286-1293
[34.]
S. Nagai, M. Kitaichi, H. Itoh, K. Nishimura, T. Izumi, T.V. Colby.
Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP.
Eur Respir J, 12 (1998), pp. 1010-1019
[35.]
Z.D. Daniil, F.C. Gilchrist, A.G. Nicholson, D.M. Hansell, J. Harris, T.V. Colby, et al.
Ahistologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.
Am J Respir Crit Care Med, 160 (1999), pp. 899-905
[36.]
W.D. Travis, K. Matsui, J. Moss, V.J. Ferrans.
Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia.
Am J Surg Pathol, 24 (2000), pp. 19-33
[37.]
American Thoracic Society.
Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratoryt Society (ERS).
Am J Respir Crit Care Med, 161 (2000), pp. 646-664
[38.]
C.S. Park, S.W. Chung, S.Y. Ki, G.I. Lim, S.T. Uh, Y.H. Kim, et al.
Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar lavage fluids of idiopathic nonspecific interstitial pneumonia.
Am J Respir Crit Care Med, 162 (2000), pp. 1162-1168
[39.]
M. Selman, T.E. King, A. Rubio.
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.
Ann Intern Med, 134 (2001), pp. 136-151
[40.]
M. Suga, K. Yyonaga, T. Okamoto, Y. Gushima, H. Miyakawa, T. Akaike, et al.
Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias.
Am J Respir Crit Care Med, 162 (2000), pp. 1949-1956
[41.]
S. Katoh, N. Matsumoto, K. Fukushima, H. Mukae, J.I. Kadota, S. Kohno, et al.
Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
J Allergy Clin Immunol, 106 (2000), pp. 730-736
[42.]
K.M. Tchou-Wong, T.J. Harkin, C. Chi, M. Bodkin, W.N. Rom.
GMCSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis.
Am J Respir Crit Care Med, 156 (1997), pp. 1999-2002
[43.]
T. Kitamura, K. Uchida, N. Tanaka, T. Tsuchiya, J. Watanabe, Y. Yamada, et al.
Idiopathic pulmonary alveolar proteinosis as an autoimmune diseae with neutralizing antibody against granulocytemacrophage colony stimulating factor.
J Exp Med, 190 (1999), pp. 875-880
[44.]
U. Dirksen, U. Nishinakamura, P. Groneck, U. Hattenhorst, L. Nogee, R. Murray, et al.
Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common β chain expression.
J Clin Invest, 100 (1997), pp. 2211-2217
[45.]
T. Kitamura, K. Uchida, M. Tanaka, T. Tsuchiya, J. Watanabe, Y. Yamada, et al.
Serological diagnosis of idiopathic pulmonary alveolar proteinosis.
Am J Respir Crit Care Med, 162 (2000), pp. 658-662
Copyright © 2002. Sociedad Española de Neumología y Cirugía Torácica
